China · Delayed Price · Currency is CNY PhiChem Statistics
Total Valuation
PhiChem has a market cap or net worth of CNY 21.53 billion. The enterprise value is 20.88 billion.
| Market Cap | 21.53B |
| Enterprise Value | 20.88B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Jul 9, 2026 |
Share Statistics
PhiChem has 570.03 million shares outstanding. The number of shares has increased by 4.83% in one year.
| Current Share Class | 570.03M |
| Shares Outstanding | 570.03M |
| Shares Change (YoY) | +4.83% |
| Shares Change (QoQ) | -0.73% |
| Owned by Insiders (%) | 1.08% |
| Owned by Institutions (%) | 8.67% |
| Float | 428.45M |
Valuation Ratios
The trailing PE ratio is 61.55 and the forward PE ratio is 35.97.
| PE Ratio | 61.55 |
| Forward PE | 35.97 |
| PS Ratio | 6.67 |
| PB Ratio | 4.27 |
| P/TBV Ratio | 5.69 |
| P/FCF Ratio | 122.84 |
| P/OCF Ratio | 32.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.59, with an EV/FCF ratio of 119.14.
| EV / Earnings | 53.49 |
| EV / Sales | 6.76 |
| EV / EBITDA | 35.59 |
| EV / EBIT | 52.88 |
| EV / FCF | 119.14 |
Financial Position
The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.15.
| Current Ratio | 2.18 |
| Quick Ratio | 1.66 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 1.07 |
| Debt / FCF | 4.45 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 8.86% and return on invested capital (ROIC) is 9.36%.
| Return on Equity (ROE) | 8.86% |
| Return on Assets (ROA) | 4.57% |
| Return on Invested Capital (ROIC) | 9.36% |
| Return on Capital Employed (ROCE) | 9.22% |
| Weighted Average Cost of Capital (WACC) | 9.62% |
| Revenue Per Employee | 1.53M |
| Profits Per Employee | 185,550 |
| Employee Count | 2,104 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 3.05 |
Taxes
In the past 12 months, PhiChem has paid 62.74 million in taxes.
| Income Tax | 62.74M |
| Effective Tax Rate | 13.34% |
Stock Price Statistics
The stock price has increased by +47.94% in the last 52 weeks. The beta is 1.04, so PhiChem's price volatility has been similar to the market average.
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +47.94% |
| 50-Day Moving Average | 35.02 |
| 200-Day Moving Average | 33.07 |
| Relative Strength Index (RSI) | 56.54 |
| Average Volume (20 Days) | 31,852,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PhiChem had revenue of CNY 3.23 billion and earned 390.40 million in profits. Earnings per share was 0.71.
| Revenue | 3.23B |
| Gross Profit | 1.17B |
| Operating Income | 496.84M |
| Pretax Income | 470.19M |
| Net Income | 390.40M |
| EBITDA | 721.44M |
| EBIT | 496.84M |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 1.33 billion in cash and 779.32 million in debt, with a net cash position of 547.68 million or 0.96 per share.
| Cash & Cash Equivalents | 1.33B |
| Total Debt | 779.32M |
| Net Cash | 547.68M |
| Net Cash Per Share | 0.96 |
| Equity (Book Value) | 5.05B |
| Book Value Per Share | 8.88 |
| Working Capital | 1.91B |
Cash Flow
In the last 12 months, operating cash flow was 669.18 million and capital expenditures -493.90 million, giving a free cash flow of 175.28 million.
| Operating Cash Flow | 669.18M |
| Capital Expenditures | -493.90M |
| Depreciation & Amortization | 224.60M |
| Net Borrowing | -211.56M |
| Free Cash Flow | 175.28M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 36.41%, with operating and profit margins of 15.40% and 12.10%.
| Gross Margin | 36.41% |
| Operating Margin | 15.40% |
| Pretax Margin | 14.58% |
| Profit Margin | 12.10% |
| EBITDA Margin | 22.37% |
| EBIT Margin | 15.40% |
| FCF Margin | 5.43% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 0.30%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 0.30% |
| Dividend Growth (YoY) | 21.05% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 21.79% |
| FCF Payout Ratio | 37.40% |
| Buyback Yield | -4.83% |
| Shareholder Yield | -4.52% |
| Earnings Yield | 1.81% |
| FCF Yield | 0.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for PhiChem is 28.90, which is -23.48% lower than the current price. The consensus rating is "Buy".
| Price Target | 28.90 |
| Price Target Difference | -23.48% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 13.22% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 15, 2019. It was a forward split with a ratio of 1.2.
| Last Split Date | May 15, 2019 |
| Split Type | Forward |
| Split Ratio | 1.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |